Jurandyr Moreira de Andrade

6PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 09, 2024
Potential biomarkers as a predictive factor of response to primary chemotherapy in breast cancer patients.

F O Buono, R D S Pugliese, W A da Silveira

|Aug 23, 2024
Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer.

Maria Fernanda Imperio Pereira, Isabela Panzeri Carlotti Buzatto, Hélio Humberto Angotti Carrara

|Jan 16, 2024
Intestinal P-gp activity is reduced in postmenopausal women under breast cancer therapy.

Joao Paulo B Ximenez, Jurandyr Moreira de Andrade, Adriana Rocha

|Nov 09, 2022
Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil.

M B Magário, R R Dos Santos, L A Teixeira

|Sep 22, 2021
A propensity score-matched case-control study of laparoscopy and laparotomy for endometrial cancer.

Licerio Miguel, Julio Cesar Rosa E Silva, Omero Benedito Poli Neto

|Aug 18, 2021
Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients.

L F Orlandini, F F Pimentel, J M de Andrade

Pageof 1